(Q37738569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Chronic myelogenous leukemia stem cells: What's new? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Mhairi Copland

series ordinal

1

1 reference

22 August 2017

language of work or name

1 reference

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

Current hematologic malignancy reports

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

66-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations

1 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11899-009-0010-9

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors

21 January 2018

1 reference

12 December 2020

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

12 December 2020

Getting to the stem of chronic myeloid leukaemia

1 reference

12 December 2020

Leukemia stem cells in a genetically defined murine model of blast-crisis CML.

1 reference

12 December 2020

Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate

1 reference

12 December 2020

Effect of cellular quiescence on the success of targeted CML therapy

1 reference

12 December 2020

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells

1 reference

12 December 2020

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells

1 reference

12 December 2020

CXCR4 is required for the quiescence of primitive hematopoietic cells

1 reference

12 December 2020

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

12 December 2020

Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.

1 reference

12 December 2020

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

1 reference

12 December 2020

Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia

1 reference

12 December 2020

Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia

1 reference

12 December 2020

CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells

1 reference

12 December 2020

beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia

1 reference

12 December 2020

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.

1 reference

12 December 2020

High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.

1 reference

12 December 2020

Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells

1 reference

12 December 2020

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo

1 reference

12 December 2020

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications.

1 reference

12 December 2020

PML targeting eradicates quiescent leukaemia-initiating cells

1 reference

12 December 2020

Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis

1 reference

12 December 2020

From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way.

1 reference

12 December 2020

Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications

1 reference

12 December 2020

p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression

1 reference

12 December 2020

Dynamics of chronic myeloid leukaemia.

1 reference

12 December 2020

Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.

1 reference

12 December 2020

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

1 reference

12 December 2020

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

12 December 2020

Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation

1 reference

12 December 2020

Gene expression changes associated with progression and response in chronic myeloid leukemia

1 reference

12 December 2020

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)

1 reference

12 December 2020

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

12 December 2020

Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies

1 reference

12 December 2020

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

12 December 2020

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

1 reference

12 December 2020

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

12 December 2020

Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.

1 reference

12 December 2020

Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606.

1 reference

12 December 2020

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

1 reference

12 December 2020

BCR-ABL-transformed GMP as myeloid leukemic stem cells

1 reference

12 December 2020

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

1 reference

12 December 2020

Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment

1 reference

12 December 2020

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

12 December 2020

10.1007/S11899-009-0010-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20425417%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference